Originally Published on July 7, 2014 by admin

As stated from the Oral Cancer Foundation, “Close to 43,250 Americans will be diagnosed with oral or pharyngeal cancer this year. It will cause over 8,000 deaths, killing roughly 1 person per hour, 24 hours per day. Of those 43,250 newly diagnosed individuals, only slightly more than half will be alive in 5 years. (Approximately 57%) This is a number which has not significantly improved in decades. (The survival number at 5 years from diagnosis was for many decades about 50%, so 57% is an improvement over the last ten years. However this is due to the increase of HPV16 caused cancers which are more vulnerable to existing treatment modalities, conferring a significant survival advantage. So a change in the etiology, not improved early discovery or treatments; which are relatively unchanged from a decade ago, are not the sole cause for improvement.) The death rate for oral cancer is higher than that of cancers which we hear about routinely such as cervical cancer, Hodgkin’s lymphoma, laryngeal cancer, cancer of the testes, and endocrine system cancers such as thyroid, or skin cancer (malignant melanoma). If you expand the definition of oral and oropharyngeal cancers to include cancer of the larynx, the numbers of diagnosed cases grow to approximately 54,000 individuals, and 13,500 deaths per year in the U.S. alone. Worldwide the problem is much greater, with over 450,000 new cases being found each year.
Historically the death rate associated with this cancer is particularly high not because it is hard to discover or diagnose, but due to the cancer being routinely discovered late in its development.”

VELscope provides the most powerful technology available for assisting in the discovery of oral mucosal abnormalities. When used as an adjunctive aid in combination with traditional oral cancer examination procedures, VELscope facilitates the early discovery and visualization of mucosal abnormalities, including oral cancer. In one or two minutes, with no rinses or stains required, a VELscope system examination, which utilizes a safe blue light, helps healthcare professionals assess their patients’ overall oral health.

Detecting oral abnormalities early leads to more treatment options, potentially less invasive or radical treatments and better patient outcomes.
We offer a lifetime of Oral Cancer screenings for only a low/one time fee of $35.00. Call us today to schedule an appointment that could save your life.